ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2023
Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease.
Open access · bronzeAbstract read
In one paragraph
Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 17 citations in OpenAlex.
- Associations of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026Article
- Analysis of the off-target interaction of amyloid PET tracers with human brain sulfotransferases.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026Article
- Tau-PET and CSF MTBR-tau243 comparisons validate increased tau aggregation in females.European journal of nuclear medicine and molecular imaging · 2026Article
- Age predicts Alzheimer's in Down syndrome better than MRI, plasma, or cognition.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026Article
- Comparison of visual and analytic methods of Alzheimer's disease pathologic staging.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- Inflammatory Bridges: Interconnections Between Alzheimer's Disease and Bone Health.Aging and disease · 2025Review
- Head-to-head comparison of tau PET tracers [Alzheimer's research & therapy · 2024Article
- Novel β-amyloid PET Imaging Study of [ACS omega · 2024Article
- Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?International journal of molecular sciences · 2024Review
- Triptolide activates the Nrf2 signaling pathway and inhibits the NF-κB signaling pathway to improve Alzheimer disease.Metabolic brain disease · 2024Review
- Test-retest performance of [Imaging neuroscience (Cambridge, Mass.) · 2024Article
- Contribution of extracerebral tracer retention and partial volume effects to sex differences in Flortaucipir-PET signal.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024Article
- MRI-free processing of tau PET images for early detection.Imaging neuroscience (Cambridge, Mass.) · 2024Article
- Age-, sex-, and pathology-related variability in brain structure and cognition.Translational psychiatry · 2023Article
- Effect and mechanism of acupuncture on Alzheimer's disease: A review.Frontiers in aging neuroscience · 2023Review
- Variable Aβ tracer uptake in hyperostosis frontalis interna: implications for brain Aβ PET/CT interpretation.Alzheimer's & dementia (Amsterdam, Netherlands)Article
- Explaining variability in early stages of [18F]-flortaucipir tau-PET binding: Focus on sex differences.Alzheimer's & dementia (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 4 institutions in 1 country.
Shaney FloresDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Charles D ChenDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Yi SuBanner Alzheimer's Institute, Phoenix, Arizona.
Aylin DincerDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Sarah J KeefeDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Nicole S McKayDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Angela M PaulickDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Gloria Guzman Perez-CarrilloDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Liang WangDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Russ C HornbeckDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Manu GoyalDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Andrei VlassenkoDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Sally SchwarzDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Michael L NickelsDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Dean F WongDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Zhude TuDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Jonathan E McConathyUniversity of Alabama at Birmingham, Birmingham, Alabama.
John C MorrisDepartment of Neurology, Washington University School of Medicine, St. Louis, Missouri.
Tammie L S BenzingerDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri.
Brian A GordonDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri; bagordon@wustl.edu.
Washington University in St. Louis · USHope Center for Neurological Disorders · USBanner Alzheimer’s InstituteUniversity of Alabama at Birmingham · US
Funding
Smartphone-Based "Burst" Cognitive AssessmentsP01AG003991 · NIA · WASHINGTON UNIVERSITY · PI JOHN MORRIS · 1985 to 2026
$69.5MThe natural history of AB accumulation in preclinical ADP01AG026276 · NIA · WASHINGTON UNIVERSITY · PI SCHINDLER, SUZANNE ELIZABETH · 2005 to 2025
$49.5MWashington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4MResearch Education ComponentP30AG066444 · NIA · WASHINGTON UNIVERSITY · PI DAVID M. HOLTZMAN · 2020 to 2026
$28.7MDominantly Inherited Alzheimer's Network Trials Unit - Adaptive Prevention TrialR01AG046179 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2014 to 2019
$26.6MResearch Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI HEATHER Allyson BIMONTE-NELSON · 2021 to 2026
$24.9MPET, APOE & the Preclinical Course of Alzheimer's DiseaseR01AG031581 · NIA · BANNER ALZHEIMER'S INSTITUTE · PI CASELLI, RICHARD J., REIMAN, ERIC MICHAEL · 2008 to 2018
$16.6MAlzheimer's Prevention Initiative ADAD Colombia TrialR01AG055444 · NIA · BANNER HEALTH · PI LOPERA, FRANCISCO, REIMAN, ERIC MICHAEL · 2017 to 2022
$14.9MTHE XNAT IMAGING INFORMATICS PLATFORMR01EB009352 · NIBIB · WASHINGTON UNIVERSITY · PI Daniel Scott Marcus · 2009 to 2026
$9.3MDOMINANTLY INHERITED ALZHEIMER NETWORK TRIAL: AN OPPORTUNITY TO PREVENT DEMENTIAU01AG042791 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2013 to 2018
$8.9MNINDS CENTER CORE FOR BRAIN IMAGINGP30NS098577 · NINDS · WASHINGTON UNIVERSITY · PI HERSHEY, TAMARA G, MARCUS, DANIEL SCOTT · 2016 to 2019
$2.4MMultidisciplinary Training in Alzheimer and Related DementiasT32AG058518 · NIA · WASHINGTON UNIVERSITY · PI Eric Martin McDade, Barbara Joy Snider · 2018 to 2026
$2.3MNCATS NIH HHS UL1 TR000448NIA NIH HHS K01 AG053474NIA NIH HHS P01 AG003991NIA NIH HHS P01 AG026276NIA NIH HHS P30 AG066444NIA NIH HHS P30 AG072980NIA NIH HHS R01 AG031581NIA NIH HHS R01 AG046179NIA NIH HHS R01 AG055444NIA NIH HHS RF1 AG073424NIA NIH HHS T32 AG058518NIA NIH HHS U01 AG042791NIBIB NIH HHS R01 EB009352NIH HHS S10 OD025214NINDS NIH HHS P30 NS098577
Abstract
Off-target binding of [
Indexed as
Alzheimer DiseaseCognitive DysfunctionAmyloidAmyloid beta-PeptidesAniline CompoundsBrainCarbolinesFemaleHumansMalePositron-Emission TomographySkulltau ProteinsThiazoles2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoleAmyloidAmyloid beta-PeptidesAniline CompoundsCarbolinestau ProteinsThiazolesamyloid PEThumanoff-target bindingtau PET
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.